from The American Heritage® Dictionary of the English Language, 4th Edition
- n. Any of various acute or chronic neoplastic diseases of the bone marrow in which unrestrained proliferation of white blood cells occurs, usually accompanied by anemia, impaired blood clotting, and enlargement of the lymph nodes, liver, and spleen.
from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. A type of malignancy affecting the blood cells or blood-forming tissues.
- n. Any specific form or type of cancer of the blood-forming tissues
from The Century Dictionary and Cyclopedia
- n. Same as leucemia.
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- n. malignant neoplasm of blood-forming tissues; characterized by abnormal proliferation of leukocytes; one of the four major types of cancer
The cure rate for myeloid leukemia is 50% to 60%, says Richard Aplenc, an assistant professor of pediatrics and a specialist in AML and leukemia at the Children's Hospital of Philadelphia.
There are specialized clinical research programs and allied translational laboratory programs in leukemia, neuroblastoma, sarcoma, neuro-oncology, bone marrow transplant, survivorship and late effects.
Beverly J. Lange, MD leads the clinical research efforts in leukemia as medical director for the Division of Oncology and associate chair for clinical research in the Childrens Oncology Group.
Fast-forward to the 2001 approval of the groundbreaking drug Gleevec, which has turned chronic myeloid leukemia from a fast killer into a disease that many patients today manage with a daily pill.
About 80 percent of all childhood leukemia is acute lymphoblastic leukemia (ALL), also called acute lymphocyte or lymphoid leukemia.
The diagnosis of leukemia is based on a complete medical history and physical examination and on the following diagnostic tests:
When this happens, the leukemia is said to be in "remission".
Acute leukemia is a rapidly progressing cancer that starts in blood-forming tissue, like bone marrow, and causes the production of large numbers of white blood cells.
In the domestic cat leukemia is today a quite common cause of death.
The improvement of long-term leukemia-free survival in patients receiving Ceplene / IL-2 exceeded 50\%.